Copyright
©The Author(s) 2021.
World J Gastrointest Pharmacol Ther. Jan 5, 2021; 12(1): 1-12
Published online Jan 5, 2021. doi: 10.4292/wjgpt.v12.i1.1
Published online Jan 5, 2021. doi: 10.4292/wjgpt.v12.i1.1
Table 6 Differences between resting energy expenditure calculated using predictive formulas in cirrhotic patients with hepatocellular carcinoma, compared with indirect calorimetry (n = 118)
Mean difference | IC 95% | 1P value | |
Calorimetry X Harris Benedict formula[21] | 177 | 59.8 a 293 | 0.004 |
Calorimetry X Schofield formula[22] | 154 | 36.9 a 270 | 0.011 |
Calorimetry X WHO formula[23] | 125 | 9.1 a 240 | 0.035 |
Calorimetry X Mifflin et al[24] formula | 210 | 98.5 a 321 | 0.001 |
Calorimetry X FAO/WHO formula[17] | 120 | -2.3 a 243 | 0.054 |
Calorimetry x IOM formula[25] | 241 | 116 a 366 | < 0.001 |
Calorimetry x Cunningham formula[26] | 14 | -101 a 129 | 0.806 |
Calorimetry x McArdle et al[27] formula | 165 | 49.5 a 279 | 0.006 |
- Citation: Henz AC, Marroni CA, Silva DMD, Teixeira JM, Silveira TT, Ferreira S, Silveira AT, Schmidt NP, Stein JT, Rayn RG, Fernandes SA. Resting energy expenditure in cirrhotic patients with and without hepatocellular carcinoma. World J Gastrointest Pharmacol Ther 2021; 12(1): 1-12
- URL: https://www.wjgnet.com/2150-5349/full/v12/i1/1.htm
- DOI: https://dx.doi.org/10.4292/wjgpt.v12.i1.1